000
| 02926cam 2200385zi 4500 |
---|
001 | 9.916479 |
---|
003 | CaOODSP |
---|
005 | 20230907115309 |
---|
006 | m o d f |
---|
007 | cr mn||||||||| |
---|
008 | 221021e202304 onca ob f000 0 eng d |
---|
020 | |a9780660459301 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP5-147/2023E-PDF |
---|
245 | 00|aGuidelines for the economic evaluation of vaccination programs in Canada. |
---|
250 | |a1st edition. |
---|
264 | 1|a[Ottawa] : |bNational Advisory Committee on Immunization (NACI), |cApril 2023. |
---|
264 | 4|c©2022 |
---|
300 | |a1 online resource (143 pages) : |bcolour illustrations |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Lignes directrices pour l'évaluation économique des programmes de vaccination au Canada. |
---|
500 | |a"April 2023." |
---|
500 | |a"Pub.: 230022"--Verso of cover. |
---|
504 | |aIncludes bibliographical references. |
---|
520 | |a"This is the first edition of the National Advisory Committee on Immunization (NACI) Guidelines on the Economic Evaluation of Vaccination Programs in Canada; in the text hereafter, they will be referred to as the Guidelines. These Guidelines have been established to articulate best practices for conducting and reporting economic evaluations of vaccination programs in Canada, be they regional, provincial, territorial, or national programs. Adherence to common best practices can allow decision-makers in Canada's publicly funded health system to have access to consistent and credible information to inform funding decisions related to vaccination programs. The Canadian Agency for Drugs and Technologies in Health's (CADTH's) Guidelines for the Economic Evaluation of Health Technologies: Canada present more general information applicable to health technologies in Canada. Health technologies can refer to devices, medicines, procedures, and systems. Where CADTH's Guideline Statements are applicable to economic evaluations of vaccination programs, they have been included in these Guidelines"--Introduction, page 32. |
---|
650 | 0|aVaccination|xEconomic aspects|zCanada|xEvaluation. |
---|
650 | 0|aVaccination|zCanada|xCosts|xEvaluation. |
---|
710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
---|
775 | 08|tLignes directrices pour l'évaluation économique des programmes de vaccination au Canada.|w(CaOODSP)9.916480 |
---|
856 | 40|qPDF|s1.68 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-147-2023-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/methods-process/incorporating-economic-evidence-federal-vaccine-recommendations/guidelines-evaluation-vaccination-programs-canada.html |
---|